SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-113033
Filing Date
2022-04-21
Accepted
2022-04-21 16:19:18
Documents
45
Period of Report
2022-04-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d353305d8k.htm   iXBRL 8-K 27159
2 EX-99.1 d353305dex991.htm EX-99.1 39731
6 GRAPHIC g353305ex99_1s10g1.jpg GRAPHIC 390612
7 GRAPHIC g353305ex99_1s11g1.jpg GRAPHIC 217392
8 GRAPHIC g353305ex99_1s12g1.jpg GRAPHIC 319983
9 GRAPHIC g353305ex99_1s13g1.jpg GRAPHIC 253934
10 GRAPHIC g353305ex99_1s14g1.jpg GRAPHIC 381837
11 GRAPHIC g353305ex99_1s15g1.jpg GRAPHIC 254308
12 GRAPHIC g353305ex99_1s16g1.jpg GRAPHIC 267983
13 GRAPHIC g353305ex99_1s17g1.jpg GRAPHIC 227626
14 GRAPHIC g353305ex99_1s18g1.jpg GRAPHIC 331441
15 GRAPHIC g353305ex99_1s19g1.jpg GRAPHIC 373489
16 GRAPHIC g353305ex99_1s1g1.jpg GRAPHIC 454715
17 GRAPHIC g353305ex99_1s20g1.jpg GRAPHIC 237096
18 GRAPHIC g353305ex99_1s21g1.jpg GRAPHIC 203155
19 GRAPHIC g353305ex99_1s22g1.jpg GRAPHIC 599724
20 GRAPHIC g353305ex99_1s23g1.jpg GRAPHIC 511002
21 GRAPHIC g353305ex99_1s24g1.jpg GRAPHIC 452812
22 GRAPHIC g353305ex99_1s25g1.jpg GRAPHIC 415272
23 GRAPHIC g353305ex99_1s26g1.jpg GRAPHIC 295421
24 GRAPHIC g353305ex99_1s27g1.jpg GRAPHIC 326397
25 GRAPHIC g353305ex99_1s28g1.jpg GRAPHIC 232971
26 GRAPHIC g353305ex99_1s29g1.jpg GRAPHIC 222998
27 GRAPHIC g353305ex99_1s2g1.jpg GRAPHIC 548581
28 GRAPHIC g353305ex99_1s30g1.jpg GRAPHIC 349982
29 GRAPHIC g353305ex99_1s31g1.jpg GRAPHIC 359554
30 GRAPHIC g353305ex99_1s32g1.jpg GRAPHIC 485715
31 GRAPHIC g353305ex99_1s3g1.jpg GRAPHIC 399803
32 GRAPHIC g353305ex99_1s4g1.jpg GRAPHIC 459284
33 GRAPHIC g353305ex99_1s5g1.jpg GRAPHIC 397547
34 GRAPHIC g353305ex99_1s6g1.jpg GRAPHIC 382803
35 GRAPHIC g353305ex99_1s7g1.jpg GRAPHIC 267253
36 GRAPHIC g353305ex99_1s8g1.jpg GRAPHIC 307556
37 GRAPHIC g353305ex99_1s9g1.jpg GRAPHIC 341882
  Complete submission text file 0001193125-22-113033.txt   15735522

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ikt-20220421.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikt-20220421_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikt-20220421_pre.xml EX-101.PRE 11714
39 EXTRACTED XBRL INSTANCE DOCUMENT d353305d8k_htm.xml XML 3469
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39676 | Film No.: 22841664
SIC: 2836 Biological Products, (No Diagnostic Substances)